A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for Helicobacter pylori eradication

Chinese Journal of Gastroenterology

Volumn 12, Issue 9, 2007, Pages 531-534

  Mu, Fanghong ^a   Hu, Fulian ^a   Yang, Guibin ^a   Cheng, Hong ^a  

^a AEROSPACE CENTER HOSPITAL   (China)

Author keywords

Drug therapy, combination; Eradication; Helicobacter pylori; Proton pump inhibitors; Safety; Treatment outcome

Indexed keywords

EID: 48249142046     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol, 2007, 102 (8): 1808-1825. (Pubitemid 47206706)
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 2007, 56 (6): 772-781. (Pubitemid 46854190)
3. Bazzoli F. Italian omeprazole triple therapy - a 1-week regimen. Scand J Gastroenterol Suppl, 1996, 215: 118. (Pubitemid 26126033)
4. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter, 1996, 1 (3): 138-144. (Pubitemid 126671139)
5. Lind T, Mégraud F, Unge P, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology, 1999, 116 (2): 248-253. (Pubitemid 29055345)
6. Katelaris PH, Forbes GM, Talley NJ, et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology, 2002, 123 (6): 1763-1769. (Pubitemid 35408299)
7. Gené E, Calvet X, Azagra R, et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther, 2003, 17 (9): 1137-1143. (Pubitemid 36605750)
8. Vakil N, Lanza F, Schwartz H, et al. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther, 2004, 20 (1): 99-107. (Pubitemid 38938723)
9. Cardenas VM, Graham DY, El-Zimaity HM, et al. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther, 2006, 23 (2): 295-301. (Pubitemid 43382040)
10. Bochenek WJ, Peters S, Fraga PD, et al. Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter, 2003, 8 (6): 626-642. (Pubitemid 37553437)
11. Ling TK, Cheng AF, Sung JJ, et al. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter, 1996, 1 (1): 57-61. (Pubitemid 126671076)
12. van der Wouden EJ, van Zwet AA, Vosmaer GD, et al. Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerg Infect Dis, 1997, 3 (3): 385-389. (Pubitemid 127431704)
13. Tankovic J, Lamarque D, Lascols C, et al. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin- clarithromycin therapy. Aliment Pharmacol Ther, 2001, 15 (5): 707-713. (Pubitemid 32385877)
14. Ducóns JA, Santolaria S, Guirao R, et al. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther, 1999, 13 (6): 775-780. (Pubitemid 29276847)
15. Lee JH, Shin JH, Roe IH, et al. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob Agents Chemother, 2005, 49 (4): 1600-1603. (Pubitemid 40463400)
16. Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther, 2007, 26 (3): 343-357. (Pubitemid 47063149)